An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
SARS-CoV-2 is causing a global pandemic in which the implementation of serology can support decision making in different scenarios. Here, the authors compare the outcome of eight commercially available assays to virus neutralization and discuss their use in diagnostics and exposure assessment of SAR...
Guardado en:
Autores principales: | Corine H. GeurtsvanKessel, Nisreen M. A. Okba, Zsofia Igloi, Susanne Bogers, Carmen W. E. Embregts, Brigitta M. Laksono, Lonneke Leijten, Casper Rokx, Bart Rijnders, Janette Rahamat-Langendoen, Johannes P. C. van den Akker, Jeroen J. A. van Kampen, Annemiek A. van der Eijk, Rob S. van Binnendijk, Bart Haagmans, Marion Koopmans |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2ac309c3223340199fb8d84c073240df |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Erratum for Sooksawasdi Na Ayudhya et al., “Enhanced Enterovirus D68 Replication in Neuroblastoma Cells Is Associated with a Cell Culture-Adaptive Amino Acid Substitution in VP1”
por: Syriam Sooksawasdi Na Ayudhya, et al.
Publicado: (2020) -
Enhanced Enterovirus D68 Replication in Neuroblastoma Cells Is Associated with a Cell Culture-Adaptive Amino Acid Substitution in VP1
por: Syriam Sooksawasdi Na Ayudhya, et al.
Publicado: (2020) -
Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
por: Arvind Gharbharan, et al.
Publicado: (2021) -
Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)
por: Jeroen J. A. van Kampen, et al.
Publicado: (2021) -
Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection
por: Chunyan Wang, et al.
Publicado: (2020)